A Phase Ib Open-Label, Multicenter Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab In Combination With Pirtobrutinib In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia

  • Tatarczuch, Maciej (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date27/06/25 → 26/06/27

Keywords

  • Clinical Trial
  • BO45287

Clinical Trial Phase

  • Phase I